Draft Genome Sequence of a Multidrug-Resistant Serratia marcescens Strain, Isolated from a Patient with Peritoneal Cancer in South Africa

Ashika Singh-Moodley; Olga Perovic; Senzo Mtshali; Arshad Ismail; Mushal Allam

doi:10.1128/genomeA.00580-17

Draft Genome Sequence of a Multidrug-Resistant Serratia marcescens Strain, Isolated from a Patient with Peritoneal Cancer in South Africa

Genome Announc. 2017 Jun 29;5(26):e00580-17. doi: 10.1128/genomeA.00580-17.

Authors

Ashika Singh-Moodley¹, Olga Perovic^{2

3}, Senzo Mtshali⁴, Arshad Ismail⁴, Mushal Allam⁴

Affiliations

¹ Centre for Healthcare-associated infections, Antimicrobial Resistance and Mycoses, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa ashikas@nicd.ac.za.
² Centre for Healthcare-associated infections, Antimicrobial Resistance and Mycoses, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa.
³ University of Witwatersrand, Johannesburg, South Africa.
⁴ Sequencing Core Facility, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa.

Abstract

We report here the draft genome sequence of Serratia marcescens ML2637, isolated from a South African pediatric patient in the intensive care unit with peritoneal cancer. The genome comprised 5,718,350 bp, with a 59.1% G+C content. There were 5,594 predicted genes, including 5,301 protein-coding genes, 199 pseudogenes, and 94 RNA genes.